These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

459 related articles for article (PubMed ID: 9551955)

  • 1. A new role for B cells in systemic autoimmunity: B cells promote spontaneous T cell activation in MRL-lpr/lpr mice.
    Chan O; Shlomchik MJ
    J Immunol; 1998 Jan; 160(1):51-9. PubMed ID: 9551955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B cells are required for lupus nephritis in the polygenic, Fas-intact MRL model of systemic autoimmunity.
    Chan OT; Madaio MP; Shlomchik MJ
    J Immunol; 1999 Oct; 163(7):3592-6. PubMed ID: 10490951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polyclonal B cell activation arises from different mechanisms in lupus-prone (NZB x NZW)F1 and MRL/MpJ-lpr/lpr mice.
    Merino R; Iwamoto M; Fossati L; Izui S
    J Immunol; 1993 Dec; 151(11):6509-16. PubMed ID: 7902378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repeated 0.5-Gy gamma irradiation attenuates autoimmune disease in MRL-lpr/lpr mice with suppression of CD3+CD4-CD8-B220+ T-cell proliferation and with up-regulation of CD4+CD25+Foxp3+ regulatory T cells.
    Tago F; Tsukimoto M; Nakatsukasa H; Kojima S
    Radiat Res; 2008 Jan; 169(1):59-66. PubMed ID: 18159952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T cell autoimmunity in Ig transgenic mice.
    Shinde S; Gee R; Santulli-Marotto S; Bockenstedt LK; Clarke SH; Mamula MJ
    J Immunol; 1999 Jun; 162(12):7519-24. PubMed ID: 10358207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Viral double-stranded RNA aggravates lupus nephritis through Toll-like receptor 3 on glomerular mesangial cells and antigen-presenting cells.
    Patole PS; Gröne HJ; Segerer S; Ciubar R; Belemezova E; Henger A; Kretzler M; Schlöndorff D; Anders HJ
    J Am Soc Nephrol; 2005 May; 16(5):1326-38. PubMed ID: 15772251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissociation of severe lupus-like disease from polyclonal B cell activation and IL 2 deficiency in C3H-lpr/lpr mice.
    Davidson WF; Roths JB; Holmes KL; Rudikoff E; Morse HC
    J Immunol; 1984 Aug; 133(2):1048-56. PubMed ID: 6610701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Functional analysis of an autoantigen reactive B cell clone derived from MRL/MP-lpr/lpr mice].
    Kobayashi K; Hamano T; Kakishita E
    Ryumachi; 1996 Dec; 36(6):844-55. PubMed ID: 9122824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemokine receptor Ccr2 deficiency reduces renal disease and prolongs survival in MRL/lpr lupus-prone mice.
    Pérez de Lema G; Maier H; Franz TJ; Escribese M; Chilla S; Segerer S; Camarasa N; Schmid H; Banas B; Kalaydjiev S; Busch DH; Pfeffer K; Mampaso F; Schlöndorff D; Luckow B
    J Am Soc Nephrol; 2005 Dec; 16(12):3592-601. PubMed ID: 16267157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Restriction of the TCR repertoire inhibits the development of memory T cells and prevents autoimmunity in lpr mice.
    Perkins DL; Listman JA; Marshak-Rothstein A; Kozlow W; Kelley VR; Finn PW; Rimm IJ
    J Immunol; 1996 Jun; 156(12):4961-8. PubMed ID: 8648148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B lymphocytes mediate Fas-dependent cytotoxicity in MRL/lpr mice.
    Bonardelle D; Benihoud K; Kiger N; Bobé P
    J Leukoc Biol; 2005 Nov; 78(5):1052-9. PubMed ID: 16204618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mouse complement receptors type 1 (CR1;CD35) and type 2 (CR2;CD21): expression on normal B cell subpopulations and decreased levels during the development of autoimmunity in MRL/lpr mice.
    Takahashi K; Kozono Y; Waldschmidt TJ; Berthiaume D; Quigg RJ; Baron A; Holers VM
    J Immunol; 1997 Aug; 159(3):1557-69. PubMed ID: 9233655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoreactive T cells with atypical MHC restriction from MRL-lpr/lpr mice: forbidden clones revisited.
    Naparstek Y; Baur K; Reis MD; Breitman L; Mak TW; Schwartz RS; Madaio MP
    J Mol Cell Immunol; 1988; 4(1):35-43. PubMed ID: 2471535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tonic B cell activation by Radioprotective105/MD-1 promotes disease progression in MRL/lpr mice.
    Kobayashi T; Takahashi K; Nagai Y; Shibata T; Otani M; Izui S; Akira S; Gotoh Y; Kiyono H; Miyake K
    Int Immunol; 2008 Jul; 20(7):881-91. PubMed ID: 18492657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unresponsiveness of MRL/MP-lpr/lpr mice to antigen given subcutaneously in adjuvant: partial restoration of response after local injection of B cells.
    Ron Y; Isakov N; Sprent J
    J Immunol; 1987 Jul; 139(2):400-5. PubMed ID: 3496379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoreactive T cells in MRL/Mpr-lpr/lpr mice. Characterization of the lymphokines produced and analysis of antigen-presenting cells required.
    Weston KM; Ju ST; Lu CY; Sy MS
    J Immunol; 1988 Sep; 141(6):1941-8. PubMed ID: 3139746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of FTY720 in MRL-lpr/lpr mice: therapeutic potential in systemic lupus erythematosus.
    Okazaki H; Hirata D; Kamimura T; Sato H; Iwamoto M; Yoshio T; Masuyama J; Fujimura A; Kobayashi E; Kano S; Minota S
    J Rheumatol; 2002 Apr; 29(4):707-16. PubMed ID: 11950011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recovery from autoimmunity of MRL/lpr mice after infection with an interleukin-2/vaccinia recombinant virus.
    Gutierrez-Ramos JC; Andreu JL; Revilla Y; Viñuela E; Martinez C
    Nature; 1990 Jul; 346(6281):271-4. PubMed ID: 1973822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigen-specific T-cell hyporesponsiveness in MRL congenic mice can be explained by two independent cellular defects.
    Waterfield JD; Fairhurst M; Chu R; Levy JG
    Immunology; 1987 Jun; 61(2):173-8. PubMed ID: 2954899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B cell genotype determines the fine specificity of autoantibody in lpr mice.
    Kakkanaiah VN; Sobel ES; MacDonald GC; Cheek RL; Cohen PL; Eisenberg RA
    J Immunol; 1997 Jul; 159(2):1027-35. PubMed ID: 9218626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.